Product
LY3457263
2 clinical trials
3 indications
Indication
Diabetes MellitusIndication
Type 2Indication
ObesityClinical trial
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3457263 Alone and in Combination With GLP-1 RA in Patients With Type 2 DiabetesStatus: Completed, Estimated PCD: 2023-11-22
Clinical trial
A Dose-Escalation Treatment, Phase 1, Investigator- and Participant-Blind, Placebo-controlled Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of LY3457263 in Combination With Tirzepatide in Overweight or Obese ParticipantsStatus: Completed, Estimated PCD: 2023-06-08